Home Keywords
Clinical Trials

Interview with Wim Souverijns, CEO of Celgene AB

Obsessed with patients

Some drugs have changed the world for good. The impact of drug research and clinical trials on improving people’s lives is profound, and it takes biopharmaceutical companies that dare to invest in medicine for all kinds of diseases. Since 1986, Celgene has cared for people with life-threatening and debilitating diseases and has focused on life-changing drugs. CEO Wim Souverijns, head of Celgene AB, stresses that Celgene challenges the status quo and aims to deliver new and better drugs every day anew. more...


Experts in preclinical research

New drug discovery is a long and difficult process that demands huge upfront investment with little guarantee of a return at the end. It is very much a numbers game: For one new drug to reach the market, at least 5,000 molecules have to be investigated. Contract research organization Pharmacelsus GmbH aids pharmaceutical companies at the preclinical stage of this research. Through its work it helps to sort the wheat from the chaff to find the molecules with the greatest potential of becoming the next drug. more...

Just enter your email address and start receiving the European Business Newsletter, free of charge, to your email inbox.

Just enter your email address and start receiving the International Trade Newsletter, free of charge, to your email inbox.

Company of the Month

amplus AG

A plus for the internet

The world wide web has continued its ascent in popularity and is considered a must in all spheres of life. It allows businesses to attract custom and new ventures to source financing. Research calls on the input of thousands of online participants. More, accessible information calls for faster and stronger internet connections, and amplus AG is up to that challenge. Nothing less than the cutting edge is good enough for the tech company.


Trending Topics
Collaboration Computer Plastics Industry Milk Marketing Yarn Waste Milk Textile Biopolymer Raw material